| Literature DB >> 26664476 |
E C Zarnescu Vasiliu1, N O Zarnescu2, R Costea2, L Rahau3, S Neagu2.
Abstract
BACKGROUND: Despite patient selection, postoperative morbidity after reversal of Hartmann's procedure remains significant. AIM: The objective of this study was to investigate risk factors associated with morbidity after conversion of Hartmann's operation. PATIENTS AND METHODS: We retrospectively analyzed data of 56 patients who underwent reversal procedures between January 2004 and May 2015 in a single center. We evaluated the following variables: demographic characteristics, medical comorbidities, etiology for Hartmann operation, preoperative lab values, intraoperative surgical details and short-term outcomes (hospital stay, medical and surgical complications, mortality).Entities:
Keywords: Hartmann’s reversal; anastomotic fistula; anastomotic leakage; colostomy closure; morbidity
Mesh:
Year: 2015 PMID: 26664476 PMCID: PMC4656958
Source DB: PubMed Journal: J Med Life ISSN: 1844-122X
Indications for Hartmann’s procedure in 56 patients with restoration of intestinal continuity
| Hartmann’s indications | Number of patients (%) | Interval (months) Hartmann – reversal (mean+SD) |
| Cancer | 25 (44.6%) | 11 ± 5.5 |
| Rectal | 6 (24%) | |
| Sigmoid | 13 (52%) | |
| Other colon location | 6 (24%) | |
| Complicated diverticulitis | 10 (17.9%) | 5.3 ± 3.7 |
| Anastomotic leakage | 4 (7.1%) | 6.7 ± 2.5 |
| Other indications | 17 (30,4%) | 8.9 ± 7 |
Outcomes after Hartmann’s reversal
| Outcomes | Number |
|---|---|
| Hospital duration of stay (days) | 11 ± 2.4 |
| Number of ICU admission | 1 (1.8%) |
| Complications* | 9 (16.1%) |
| Anastomotic leakage | 2 (3.6%) |
| Wound infection | 1 (1.8%) |
| Diarrhea syndrome | 4 (7.2%) |
| Cardiovascular complication | 2 (3.6%) |
| Hemorrhagic gastritis | 1 (1.8%) |
| Death | 2 (3.6%) |
Bivariate analysis of postoperative complications of 56 patients with Hartmann’s reversal
| Variables | No complications (N = 47) | Postoperative complications (N=9) | p-value |
|---|---|---|---|
| Male gender (N=37) | 29 (61.7%) | 8 (88.9%) | 0.113 |
| Age (years) | 56.8+14.7 | 58.5+20 | 0.510 |
| Medical comorbidities (N=23) | 18 (38.3%) | 5 (55.6%) | 0.274 |
| Multiple comorbidities (N=7) | 4 (8.5%) | 3 (33.3%) | 0.039* |
| Hartmann - conversion interval (months) | 8.5+6.3 | 11.8+10 | 0.277 |
| Hartmann’s indication | 0.900 | ||
| Cancer (N=25) | 21 (44.7%) | 4 (44.4%) | |
| Diverticulitis (N=10) | 8 (17%) | 2 (22.2%) | |
| Anastomotic leakage (N=4) | 3 (6.4%) | 1 (11.1%) | |
| Other indications (17) | 15 (31.9%) | 2 (22.2%) | |
| Cancer location – sigmoid (N=13) | 11 (52.4%) | 2 (50%) | 0.996 |
| Manual surgical technique (N=44) | 37 (78.7) | 7 (77.8%) | 0.949 |
| Type of anastomosis | 0.474 | ||
| End to end (N=32) | 27 (60%) | 5 (55.6%) | |
| End to side (N=15) | 11 (24.4%) | 4 (44.4%) | |
| Hemoglobin (g/ dL) | 13.7±1.4 | 14.1±1.7 | 0.369 |
| Total proteins (g/ dL) | 7.4±0.5 | 7.3±0.3 | 0.755 |
Morbidity after reversal of Hartmann’s operation
| Study | No of patients | Anastomotic leakage rate (%) | Morbidity (%) |
| Banerjee et al. (2005) [ | 63 | 4 (6.34%) | 26 (41%) |
| Fleming et al. (2009) [ | 76 | 1 (1.31%) | 18 (25%) |
| Schmelzer et al. (2007) [ | 113 | 1 (0.88%) | 28 (24.7%) |
| Tokode et al. (2011) [ | 51 | 4 (7.8%) | 19 (37.3%) |
| Tan et al. (2012) [ | 46 | 0 (0.0%) | 10 (20.4%) |
| Our study | 56 | 2 (3.6%) | 9 (16.1%) |